Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice.

AUTOR(ES)

Furney, S K

RESUMO

Disseminated Mycobacterium avium infection is the major cause of bacteremia in patients with acquired immunodeficiency syndrome. We present here a new animal model of this disease, thymectomized C57BL/6 mice that were intravenously infused with monoclonal antibody to selectively deplete CD4+ T cells. The increased susceptibility of such animals to M. avium infection is comparable to that of C57BL/6 beige mice and thus may provide a viable alternative to the latter model. Further, using representative strains of acquired immunodeficiency syndrome-associated M. avium (serotypes 1, 4, and 8 and a rough isolate), we show that the course of such infections in thymectomized, CD4-deficient mice can be markedly restrained and in some cases the infections can be sterilized by treatment over a 120-day period with a regimen containing 40 mg of the new antimycobacterial agent rifabutin per kg (body weight).

Documentos Relacionados

• Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.
• Massive Apoptosis of Thymocytes in T-Cell-Deficient Id1 Transgenic Mice
• T-cell-deficient mice display normal recovery from experimental rotavirus infection.
• New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
• Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice.